All News

Managing comorbidities, ensuring proper dosing, and treating IVIG-related adverse events are areas where pharmacists play a large role.

The new Medicare cap limits out-of-pocket drug costs to $2000 annually.

Pharmacy Times interviews Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, about glucagon-like peptide-1 receptors for diabetes treatment.

Hokkaido scallop oil plasmalogen and Apoaequorin have both been posited to improve brain health.

If approved, nipocalimab can treat antibody positive individuals with generalized myasthenia gravis.

The Kidney Disease: Improving Global Outcomes guidelines can provide pharmacists with approaches to minimizing chronic kidney disease progression and complications.

Virtual appointments were also an accessible alternative to in-person visits for patients who face obstacles accessing asthma care.

The proposed age restrictions on dietary supplements would limit consumer access to safe products.

The designation was supported by data from the phase 2, open-label, randomized, multi-center ARTEMIS-002 clinical trial, which assessed the safety and efficacy of GSK’227.

Pharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.

Some patients treated with prolonged courses of oral nirmatrelvir/ritonavir experienced long COVID symptom improvements, while others reported little to no changes in their symptoms.

Inclusion of AI improved detection and reduced instances of false-positive test results.

Limited access to healthy food in redlined communities contributes to higher rates of chronic disease and reduced life expectancy.

As of January 10, there are 5 major fires across a combined 36,560 acres—Palisades, Eaton, Kenneth, Hurst, and Lidia—and the 2 largest fires are a combined 11% contained.

While waiting for budgetary approvals, there are some simple initiatives outpatient oncology practices can initiate that yield high rewards and quick wins yet cost little more than an investment of time.

The pharmacist’s role includes educating and making recommendations, collaborating with health care professionals, and observing early signs of cognitive impairment in patients during interactions.

Invikafusp alfa (STAR0602; Marengo Therapeutics Inc) is being investigated as a treatment for advanced colorectal cancer with high tumor mutational burden.

The observational study shows a positive correlation between smoking and chronic kidney disease (CKD) whereas the analyses imply smoking-related covariates may be a factor.

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

The designation follows positive phase 2a trial results (NCT05104853) presented at the 2024 AASLD The Liver Meeting.

ALG-801 could present new opportunities to improve treatment and management of patients with pulmonary arterial hypertension, a life-threatening condition.

In a phase 2 trial (NCT05400226), abenacianine helps surgeons visualize tumors in lung during surgery and is safe and well-tolerated in patients.

Serplulimab plus HLX04 demonstrates a favorable safety profile in patients with advanced hepatocellular carcinoma.

The late former president played a critical role in advancing cancer care, as well as efforts to eradicate preventable diseases.

These new regulatory developments put CUTX-101 on track to become the first FDA-approved treatment for patients with Menkes disease.

For patients with multiple myeloma who may experience an infection while receiving teclistamab, supplementation with intravenous immunoglobulin (IVIG) can help resolve and prevent serious complications.

High-cost medications necessary for treatment require close management to ensure patient safety and to adhere to payer-specific requirements.

Duchenne muscular dystrophy is an incurable neuromuscular disorder that can lead to cardiomyopathy, resulting in heart failure.

Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.

The new designation for the selective PPAR⍺ antagonist follows positive phase 1b/2 clinical trial results.